Physician profile
Lawrence Born
NPI 1003818626
$1,123.83
in general payments reported to CMS, 2019-2025
20 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.05 · 2020: $59.10 · 2021: $305 · 2022: $222 · 2023: $217 · 2024: $127 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $196.84 | 2019-2022 | |
| Abbvie INC. | $190.57 | 2020-2025 | Rinvoq, Mavyret |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $178.82 | 2020-2025 | Xifaxan, Trulance |
| Celgene Corporation | $112.89 | 2021-2024 | Zeposia |
| Janssen Biotech, INC. | $68.26 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $66.72 | 2021-2023 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $48.45 | 2023-2025 | Dupixent |
| Nestle Healthcare Nutrition INC. | $37.71 | 2021 | |
| Pfizer INC. | $34.85 | 2022 | |
| Aimmune Therapeutics, INC. | $25.84 | 2024 | |
| Lilly USA, LLC | $21.63 | 2024 | Omvoh |
| Redhill Biopharma INC. | $20.86 | 2021 | |
| Terumo Medical Corporation | $19.50 | 2024 | Azur Cx Detachable |
| Phathom Pharmaceuticals, INC. | $19.44 | 2025 | Voquezna |
| Axonics, INC. | $19.21 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.95 | 2020 | |
| Braintree Laboratories, INC. | $17.77 | 2021 | |
| Medtronic, INC. | $15.91 | 2025 | Intellis Adaptivestim |
| Mauna Kea Technologies, INC. | $5.49 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $5.12 | 2024 | Riteclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Born listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.